BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 8050579)

  • 1. Shark class II invariant chain reveals ancient conserved relationships with cathepsins and MHC class II.
    Criscitiello MF; Ohta Y; Graham MD; Eubanks JO; Chen PL; Flajnik MF
    Dev Comp Immunol; 2012 Mar; 36(3):521-33. PubMed ID: 21996610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introducing endogenous antigens into the major histocompatibility complex (MHC) class II presentation pathway. Both Ii mediated inhibition and enhancement of endogenous peptide/MHC class II presentation require the same Ii domains.
    Frauwirth K; Shastri N
    Immunology; 2001 Apr; 102(4):405-15. PubMed ID: 11328374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invariant chain controls H2-M proteolysis in mouse splenocytes and dendritic cells.
    Pierre P; Shachar I; Matza D; Gatti E; Flavell RA; Mellman I
    J Exp Med; 2000 Mar; 191(6):1057-62. PubMed ID: 10727467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Friends and relations of the cystatin superfamily--new members and their evolution.
    Brown WM; Dziegielewska KM
    Protein Sci; 1997 Jan; 6(1):5-12. PubMed ID: 9007972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological functions of endosomal proteolysis.
    Berg T; Gjøen T; Bakke O
    Biochem J; 1995 Apr; 307 ( Pt 2)(Pt 2):313-26. PubMed ID: 7733863
    [No Abstract]   [Full Text] [Related]  

  • 6. The p41 fragment story.
    Turk D; Guncar G; Turk V
    IUBMB Life; 1999 Jul; 48(1):7-12. PubMed ID: 10791909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S.
    Guncar G; Pungercic G; Klemencic I; Turk V; Turk D
    EMBO J; 1999 Feb; 18(4):793-803. PubMed ID: 10022822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.
    Bevec T; Stoka V; Pungercic G; Dolenc I; Turk V
    J Exp Med; 1996 Apr; 183(4):1331-8. PubMed ID: 8666891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential sites for processing of the human invariant chain by cathepsins D and E.
    Kageyama T; Yonezawa S; Ichinose M; Miki K; Moriyama A
    Biochem Biophys Res Commun; 1996 Jun; 223(3):549-53. PubMed ID: 8687433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism and regulation of antigen processing by cathepsin B.
    Katunuma N; Matsunaga Y; Saibara T
    Adv Enzyme Regul; 1994; 34():145-58. PubMed ID: 7942272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading.
    Riese RJ; Wolf PR; Brömme D; Natkin LR; Villadangos JA; Ploegh HL; Chapman HA
    Immunity; 1996 Apr; 4(4):357-66. PubMed ID: 8612130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological significances of invariant chain from the aspect of its structural homology with the cystatin family.
    Katunuma N; Kakegawa H; Matsunaga Y; Saibara T
    FEBS Lett; 1994 Aug; 349(2):265-9. PubMed ID: 8050579
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.